Literature DB >> 15225127

Modulation of the firing activity of female dorsal raphe nucleus serotonergic neurons by neuroactive steroids.

M Robichaud1, G Debonnel.   

Abstract

Important gender differences in mood disorders result in a greater susceptibility for women. Accumulating evidence suggests a reciprocal modulation between the 5-hydroxytryptamine (5-HT) system and neuroactive steroids. Previous data from our laboratory have shown that during pregnancy, the firing activity of 5-HT neurons increases in parallel with progesterone levels. This study was undertaken to evaluate the putative modulation of the 5-HT neuronal firing activity by different neurosteroids. Female rats received i.c.v. for 7 days a dose of 50 micro g/kg per day of one of the following steroids: progesterone, pregnenolone, 5beta-pregnane-3,20-dione (5beta-DHP), 5beta-pregnan-3alpha-ol,20-one, 5beta-pregnan-3beta-ol,20-one, 5alpha-pregnane-3,20-dione, 5alpha-pregnan-3alpha-ol,20-one (allopregnanolone, 3alpha,5alpha-THP), 5alpha-pregnane-3beta-ol,20-one and dehydroepiandrosterone (DHEA). 5beta-DHP and DHEA were also administered for 14 and 21 days (50 micro g/kg per day, i.c.v.) as well as concomitantly with the selective sigma 1 (sigma1) receptor antagonist NE-100. In vivo, extracellular unitary recording of 5-HT neurons performed in the dorsal raphe nucleus of these rats revealed that DHEA, 5beta-DHP and 3alpha,5alpha-THP significantly increased the firing activity of the 5-HT neurons. Interestingly, 5beta-DHP and DHEA showed different time-frames for their effects with 5beta-DHP having its greatest effect after 7 days to return to control values after 21 days, whereas DHEA demonstrated a sustained effect over the 21 day period. NE-100 prevented the effect of DHEA but not of 5beta-DHP, thus indicating that its sigma1 receptors mediate the effect of DHEA but not that of 5beta-DHP. In conclusion, our results offer a cellular basis for potential antidepressant effects of neurosteroids, which may prove important particularly for women with affective disorders.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15225127     DOI: 10.1677/joe.0.1820011

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  12 in total

1.  Serotonin-specific lesions of the dorsal raphe disrupt maternal aggression and caregiving in postpartum rats.

Authors:  M Allie Holschbach; Erika M Vitale; Joseph S Lonstein
Journal:  Behav Brain Res       Date:  2018-04-10       Impact factor: 3.332

2.  Effects of DHEA administration on episodic memory, cortisol and mood in healthy young men: a double-blind, placebo-controlled study.

Authors:  Hamid A Alhaj; Anna E Massey; R Hamish McAllister-Williams
Journal:  Psychopharmacology (Berl)       Date:  2005-10-18       Impact factor: 4.530

Review 3.  Sigma-1 Receptors in Depression: Mechanism and Therapeutic Development.

Authors:  Peng Ren; Jingya Wang; Nanxi Li; Guangxiang Li; Hui Ma; Yongqi Zhao; Yunfeng Li
Journal:  Front Pharmacol       Date:  2022-06-16       Impact factor: 5.988

Review 4.  The pharmacology of sigma-1 receptors.

Authors:  Tangui Maurice; Tsung-Ping Su
Journal:  Pharmacol Ther       Date:  2009-07-18       Impact factor: 12.310

Review 5.  Innovative approaches for the development of antidepressant drugs: current and future strategies.

Authors:  Lee E Schechter; Robert H Ring; Chad E Beyer; Zoë A Hughes; Xavier Khawaja; Jessica E Malberg; Sharon Rosenzweig-Lipson
Journal:  NeuroRx       Date:  2005-10

Review 6.  Reproductive hormone sensitivity and risk for depression across the female life cycle: a continuum of vulnerability?

Authors:  Claudio N Soares; Brook Zitek
Journal:  J Psychiatry Neurosci       Date:  2008-07       Impact factor: 6.186

7.  Investigating the motivational mechanism of altered saline consumption following 5-HT(1A) manipulation.

Authors:  Melissa L Caras; Kimberly MacKenzie; Benjamin Rodwin; Donald B Katz
Journal:  Behav Neurosci       Date:  2008-04       Impact factor: 1.912

8.  Rapid response to fluoxetine in women with premenstrual dysphoric disorder.

Authors:  Emma M Steinberg; Graca M P Cardoso; Pedro E Martinez; David R Rubinow; Peter J Schmidt
Journal:  Depress Anxiety       Date:  2012-05-04       Impact factor: 6.505

Review 9.  A review of age-related dehydroepiandrosterone decline and its association with well-known geriatric syndromes: is treatment beneficial?

Authors:  Nikolaos Samaras; Dimitrios Samaras; Emilia Frangos; Alexandre Forster; Jacques Philippe
Journal:  Rejuvenation Res       Date:  2013-08       Impact factor: 4.663

10.  Higher serum dehydroepiandrosterone sulfate protects against the onset of depression in the elderly: Findings from the English Longitudinal Study of Aging (ELSA).

Authors:  Luis H Souza-Teodoro; Cesar de Oliveira; Kate Walters; Livia A Carvalho
Journal:  Psychoneuroendocrinology       Date:  2015-11-12       Impact factor: 4.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.